Skip to main content
OpenTrials

Clinical trial condition

Attention Deficit Disorder with Hyperactivity

Explore clinical trials studying Attention Deficit Disorder with Hyperactivity. Study availability and eligibility vary by location and protocol.

1,408 public trials 160 recruiting studies
Refine in advanced search Browse all conditions

Attention Deficit Disorder with Hyperactivity trial results

Completed

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) Low Dose in Children With ADHD

NCT03247530

Conditions
ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • Harmonex Neuroscience Research Dothan, Alabama, United States
  • Indago Research & Health Center, Inc. Hialeah, Florida, United States
  • Advanced Clinical Research Meridian, Idaho, United States
  • Finger Lakes Clinical Research Rochester, New York, United States
View Trial Details
Completed

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) High Dose in Adolescents With ADHD

NCT03247556

Conditions
ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • Alliance for Wellness dba Alliance for Research Long Beach, California, United States
  • MCB Clinical Research Centers, LLC Colorado Springs, Colorado, United States
  • Meridien Research at Florida Clinical Research Center Bradenton, Florida, United States
  • Innovative Clinical Research, Inc Lauderhill, Florida, United States
View all 14 locations
View Trial Details
Completed

Efficacy and Safety of Extended-release Guanfacine Hydrochloride in Children and Adolescents Aged 6-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)

NCT01244490

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • Psychiatric Centers at San Diego, Feighner Research San Diego, California, United States
  • Florida Clinical Research Center, LLC Maitland, Florida, United States
  • Atlanta Center for Medical Research Atlanta, Georgia, United States
  • Psychiatric Associates Overland Park, Kansas, United States
View all 66 locations
View Trial Details
Completed

KP415 Classroom Study in Children (6-12 Years of Age) With ADHD

NCT03292952

Conditions
ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • Meridien Research Bradenton, Florida, United States
  • Meridien Research Maitland, Florida, United States
  • Center for Psychiatry and Behavioral Medicine, Inc. Las Vegas, Nevada, United States
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details
Completed

A Trial Evaluating the Efficacy and Safety of HLD200 in Children With ADHD

NCT02255513

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • AVIDA, Inc. Newport Beach, California, United States
  • South Shore Psychiatric Services, PC Marshfield, Massachusetts, United States
  • Center for Psychiatry and Behavioral Medicine, Inc. Las Vegas, Nevada, United States
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details
Completed

Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl

NCT01081132

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, Attention-Deficit/Hyperactivity Disorder, +2 more
Locations
  • Harmonex Neuroscience Research Dothan, Alabama, United States
  • Clinical Study Centers, LLC Little Rock, Arkansas, United States
  • Peninsula Research Associates Rolling Hills Estates, California, United States
  • Psychiatric Centers at San Diego (PCSD-Feighner Research Institute) San Diego, California, United States
View all 54 locations
View Trial Details
Completed

Safety and Efficacy of SPD465 in Adults With ADHD

NCT00202605

Conditions
Attention Deficit Disorder With Hyperactivity, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • Clinical Study Center Little Rock, Arkansas, United States
  • UCI Child Development Center Irvine, California, United States
  • Center for Psychiatry and Behavioral Medicine, Inc. Las Vegas, Nevada, United States
  • Bayou City Research, Ltd. Houston, Texas, United States
View Trial Details

Related conditions